Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
27 May, 2020 07:20 IST
Sun Pharma's Halol site classified for official action by USFDA
Source: IRIS | 30 Mar, 2020, 11.54PM
Comments  |  Post Comment

India's largest drug maker Sun Pharmaceutical (Q,N,C,F)* Industries said its Halol manufacturing site in Gujarat had been classified as Official Action Indicated (OAI) by USFDA.

The OAI status implies that the USFDA may put all new approvals from the Halol facility on hold till the outstanding corrective actions are completed.

Sun Pharma will be able to manufacture and supply already-approved products from the facility to the US market.  

Shares of the company declined Rs 4.5, or 1.33%, to settle  at  Rs 333.65.  The total volume of shares traded  was  270,092 at  the BSE (Monday). 



Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Company Update
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer